Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Encapsulation of AD-MSC- derived extracellular nanovesicles in an electrospun three-layer scaffold: characterization and controlled release analysis in vitro .

Ghorbani R., Abbaszadeh HA., Ramezani R., Taghipour N., Rahimpour A., Hosseinzadeh S.

Laboratory Study on Face & Skin, published in Biomed Mater (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Biomed Mater (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
39706159
DOI
10.1088/1748-605X/ada23f
Citations
3

Abstract (original English)

The combining of therapeutic agents with electrospun nanofibers boosts their regeneration potential; therefore, Researchers have increasingly turned towards the development of electrospun nanofiber scaffolds to encapsulate or surface-adsorb biological payloads, such as cytokines, exosomes, peptides, nucleic acids, and enzymes. Due to their high surface-to-volume ratio, ease of manufacturing, and drug-loading capacity, electrospun nanofibers are hopeful in tissue engineering and scaffold fabrication. Electrospun multilayer scaffolds offer a promising construction for preserving the integrity and bioactivity of therapeutic factors while permitting the controlled and prolonged release of biomolecules into the environment. The present study aimed to evaluate the mechanism of controlled release of electrospun exosomes from a three-layer nanofiber scaffold and its effect on the expression of DDR2 and VEGF genes in fibroblast cells in vitro . Adipose-derived mesenchymal stem cells were obtained and isolated from liposuction surgery samples, and their intrinsic nature was confirmed using flow cytometry. After the exosomes were separated from the cell supernatant, their size, shape, and index markers were identified. The cytotoxicity, biocompatibility, and mechanical characteristics of scaffolds were evaluated. The qRT-PCR results showed the upregulation of DDR2 and VEGF genes in the th

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Mesenchymal Stem CellsTissue ScaffoldsHumansNanofibersTissue EngineeringDelayed-Action PreparationsVascular Endothelial Growth Factor AFibroblastsExosomesBiocompatible Materials

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research